Επιλογή Σελίδας
Οκτ 8, 2015 | Medical News, Scientific articles
By Bruno Castro, PhD In a recent study entitled, “Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension” published in the prestigious New England Journal of Medicine, a worldwide team of researchers demonstrated that treatment...Σεπ 25, 2015 | Medical News, Scientific articles
By Malika Ammam, PHD In a recent collaborative research project published in the PLOS one journal entitled “Risk Factors of Pulmonary Hypertension in Brazilian Patients with Sickle Cell Anemia,” researchers suggest that patients suffering from sickle cell anemia (SCA)...Σεπ 23, 2015 | Medical News, Scientific articles
By Alisa Woods, PhD Cytori Therapeutics recently published a report of 12-month data from the Scleradec-I clinical trial studying hand dysfunction in people with scleroderma. Findings from the 12 patient trial, which was led by Dr. Brigitte Granel and Dr. Guy Magalon...Σεπ 15, 2015 | Announcements, Medical News, Scientific articles
By Patricia Silva, PhD A study led by researchers at the Imperial College London in the United Kingdom was recently published in the journal Nature reporting the discovery of a gene involved in pulmonary hypertension pathology. The study is entitled “The zinc...Σεπ 14, 2015 | Announcements, Medical News, Scientific articles
By Patricia Silva, PhD Gilead Sciences, Inc. recently announced the publication of data in The New England Journal of Medicine concerning the AMBITION trial evaluating the combination therapy of Letairis® (ambrisentan) and tadalafil for pulmonary arterial...Σεπ 12, 2015 | Announcements, Medical News, Scientific articles
By Maureen Newman The recent announcement of positive results for the AMBITION trial testing combinatorial ambrisentan and tadalafil in patients with pulmonary arterial hypertension (PAH) is bringing more attention to the need to actively recruit participants for...
Join our mailing list to receive the latest news and updates from our team.